The Covid-19 pandemic has highlighted the importance of health technologies to mitigate against the spread of the disease and improve care, dominantly including life-saving vaccines. But the pandemic ...has also highlighted that the current biopharmaceutical business model, based on the enclosure of these technologies and on the immense accumulation of capital it enables, leads to vast inequalities in healthcare particularly in low and middle-income countries. We believe that the pharmaceutical industry has a moral duty to enable and enact global solidarity through tech sharing instead of tech hoarding, but judging by current technology transfer practices we question their willingness to assume their role in organizing healthcare markets through solidaristic principles. In the absence of a voluntary adoption of solidaristic principles and practices by biopharmaceutical firms, the institutionalization of global solidarity as a fundamental organizing principle for healthcare markets is necessary to strengthen resilience and know-how globally. With this call, we add to existing conceptualizations of solidarity by (a) introducing a global level of solidarity and (b) thinking through the concept not as an abstract humanistic stance but as a concrete organizing principle for global healthcare markets.
How do actors innovate markets in cases of perceived market failures? This paper’s aim is to examine what happens when a market is innovated or, as we call it, ‘redevised’ in situations where public ...and commercial interests significantly diverge. Market devices can serve an important function in such attempts to innovate markets: they are material and/or social arrangements that are put into place to shape the market in question in certain ways. But can such devices really transform a market from within? To examine this question we trace the history of the Geneva Medicines Patent Pool, a civil society initiative introduced to change pharmaceutical firms’ licensing and collaboration practices in the market for HIV/AIDS medicines. Our empirical results indicate that redevising a market in response to market failures can shift the market’s frames and contribute to altering its practices, but that this is a pragmatic and often lengthy process that is never fully predictable in advance. By attending to the intended and unintended consequences - or misfires - of redevising a market, our study raises important questions around acting in and on the market, market innovation’s’ ontological impact, zooming in and zooming out when studying redevising, and attending to the temporality of market innovation.
We live in an era where models of governing are changing rapidly under multifaceted evolutionary pressures and where, at the same time, organizational fields are becoming increasingly networked. With ...this paper, we add to the field dynamics literature, focusing on the space where these evolutionary pressures coincide – the interactions of Governments and interorganizational networks. We examine the roles that interorganizational networks play in relation to Government actors under particular long- and short-term institutional and governance conditions. We articulate four roles that networks may play in relation to Government: advocate, technology, judge and ruler. We argue that long-term institutional logics, combined with short-term Government action in response to a particular field evolution, may predict the role that the interorganizational network will assume in relation to Government in that particular field scenario. We discuss flows through the typology as conditions change and we conclude by presenting an agenda for future research in the field dynamics and interorganizational networks research domains that leverages our proposed network role typology.
Prior work on performativity has illustrated how theories intervene in economic organizing. We expand this body of research by studying how concepts, and particularly those that are loosely defined ...and/or not widely understood, provoke their own realities through experiments. We examine how different experimental set-ups allow these concepts to be seized by a multitude of actors all wishing to instantiate worlds in their own interests, and how they potentially open up multiple competing realities as a result. We follow the concept of mobility-as-a-service as it mobilizes various experiments across public and private realms in Stockholm and Dublin, and we analyse how specific types of experiment co-produce epistemic and ontological work. Our results illustrate how different experimental designs can be conducive in taming and/or framing ambiguous concepts through interconnected processes of such onto-epistemological work. This highlights the distributed and relational and also the ‘provocative’ facets of performing ambiguous concepts through experiments. We discuss the consequences of these insights for how we think about scaling from experiments to broader socio-economic realities.
The controversies surrounding the heavily redacted contracts between the European Commission and Covid-19 vaccine producers have highlighted ‘transparency’ as a hotly debated concept in the ...pharmaceutical market. We combine research on transparency with literature on the organization of markets to investigate how such struggles over competing visions of transparency end up shaping markets and their politics. Focusing on the case of the European pharmaceutical market, we demonstrate how market transparency was implemented through devices that enacted specific visions of transparency and produced distinct market organizations over time: transparency for states (until about 1990), transparency for corporations (ca. 1990 to 2010) and transparency for state coalitions (since 2010). We discuss how the specific instrumentations and materializations of such visions of transparency play a crucial role in market politics. This debate also highlights why engaging in controversies over transparency has become increasingly important for those contesting the market status quo – in pharmaceutical markets and beyond.
We explore the role of affect in fuelling and sustaining political organizing in the case of an online type-1 diabetes community. Analysing this community’s interactions, we show that the drive ...towards political transformation is triggered by affective dissonance, but that this dissonance needs to be recurrently enacted through the balanced circulation of objects of pain and hope. We propose the notion of affective resonance to illuminate the dynamic interplay that collectively moderates and fosters this circulation and that keeps bodies invested and reverberating together around shared political goals. Affective resonance points researchers toward the fragile and complex accomplishment that affective politics represents. Focusing particularly on the community’s interactions on Twitter, we also reflect on the role of (digital) resonance spaces in how affects circulate. By adopting and transposing concepts from affect theories into the context of patient communities, we further add important insights into the unique embodied challenges that patients with chronic illness face. Highlighting the hope induced by techno-bodily emancipation that intertwine into a particular form of political organizing in such healthcare movements, we give emphasis to patient communities’ deeply embodied affects as important engines for political, social and economic change.
•We study the relationship between regulation and innovation framed as a process.•Our focus is on environmental regulation for which products remain in circulation.•Processes are made stable in time ...through regulators’ and producers’ interactions.•We demonstrate a weak form of technological capture, supported by material agency.•Regulatory principles are mediated operationally by norms, including applied science.
This paper examines how environmental regulation is made operational when it legislates for modifications rather than the banning of products or substances. The continued circulation of such products draws attention to the heterogeneous conditions of their use and allows industry actors to accumulate evidence of the products’ polluting effects over time. We find that this agentic quality of materials – including products and sites of application – is a vital and so far largely ignored dimension in the relationship between environmental regulation and innovation. This is captured in a process we term interactive stabilization, which describes how material agency becomes a focus for interactions between regulatory and industry actors. We develop our argument through an in-depth case study of the environmental regulation of production chemistry and identify three interactive processes: formulating regulatory principles; operationalizing these principles through technical documentation and calculation; and incremental innovation as used by chemists to address clients’ varied material problems in production. We trace stabilizing and destabilizing effects across these three processes and draw particular attention to the role of uncertainty in the operationalization of precaution as a regulatory principle. We argue that this uncertainty may lead to a form of regulatory capture that we frame as technological capture. This refers to how industry actors are able to test the limits of regulatory principles and calculations and on occasion contest these through their applied science capabilities.
Entanglements between public and private entities in digital health are not new, yet we do not have full insight into how these public-private dances are choreographed or what notions of public value ...drive governments’ appetite for investing into or collaborating with private digital health firms around health data. We examine key events, actors, public discussions, policy deliberations and regulations for over 30 years to find that European Union policy has paved an innovation-friendly path for technology companies entering healthcare. The recent pandemic has normalized these collaborations even further. The paper also finds that conceptualizations of public value in digital health mostly relate to economic aspects – markets, jobs and money. Other interpretations, such as public health, long-term sustainability or the common good, tend to be sidelined. The paper closes by considering whether the advent of the European Health Data Space will change this trajectory before giving suggestions on how a focus on public health value can be re-established.
This paper reflects on the relationship between high-tech disruption narratives and uncertainty. My main argument is that an economic sociology of the future is incomplete without addressing the ...'demonic' or rather eschatological elements apparent in the promissory twin rhetoric of disruption and inevitability that a number of contemporary technology firms employ. The conjuring up of liberatory high-tech futures implicates a political-philosophical perspective of the end game. It utilizes at once the productive power of uncertainty to create visions of 'absolute riches' and societal gain but at the same time narrows these futures down to one inevitable alternative to the status quo. Through the examples of two Silicon Valley disruptor firms, I argue that these eschatological narratives need to be opened to social scientific critique in order to examine their potential societal consequences above and beyond the narrow geographic confines of 'the Valley.'
PDF
